Literature DB >> 9484945

Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue?

R M Byers1, A K El-Naggar, Y Y Lee, B Rao, B Fornage, N H Terry, D Sample, P Hankins, T L Smith, P J Wolf.   

Abstract

BACKGROUND: When to do a neck dissection as part of the surgical treatment for a patient with squamous carcinoma of the oral tongue is controversial, particularly when the primary can be resected without entering the neck. If the patient who is at high risk for having occult nodal disease in the neck can be identified, node dissection with the glossectomy could be justified. To better identify patients for this procedure, we correlated various tumor and patient factors along with preoperative diagnostic studies with the presence or absence of pathologically positive nodes in a group of patients who underwent node dissection.
METHODS: Ninety-one previously untreated patients with biopsy-proved squamous carcinoma of the oral tongue were prospectively studied. All patients had a glossectomy and neck dissection as their initial treatment. The pathology findings (ie, lymph nodes with squamous cancer) were correlated with many preoperative and intraoperative factors, and a statistical analysis was made.
RESULTS: The use of computed tomography and ultrasound was not better than the clinical examination in determining the presence or absence of nodal metastases. The best predictors were depth of muscle invasion, double DNA aneuploidy, and histologic differentiation of the tumor.
CONCLUSIONS: All patients with stage T2-T4 squamous cancers of the oral tongue should have an elective dissection of the neck. Patients with T1N0 cancer who have a double DNA-aneuploid tumor, depth of muscle invasion > 4 mm, or have a poorly differentiated cancer should definitely undergo elective neck dissection. Ultrasound and computed tomography are of little value in predicting which patients have positive nodes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9484945     DOI: 10.1002/(sici)1097-0347(199803)20:2<138::aid-hed7>3.0.co;2-3

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  54 in total

Review 1.  Management of the clinically negative (N0) neck.

Authors:  Karen T Pitman; Robert Dean
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

2.  Relationship between histologic thickness of tongue carcinoma and thickness estimated from preoperative MRI.

Authors:  Lorenzo Preda; Fausto Chiesa; Luca Calabrese; Antuono Latronico; Roberto Bruschini; Maria E Leon; Giuseppe Renne; Massimo Bellomi
Journal:  Eur Radiol       Date:  2006-04-25       Impact factor: 5.315

Review 3.  Management of cervical metastasis.

Authors:  Eric J Lentsch
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

4.  Contrast-enhanced CT and MRI for detecting neck metastasis of oral cancer: comparison between analyses performed by oral and medical radiologists.

Authors:  P T de Souza Figueiredo; A F Leite; F R Barra; R F Dos Anjos; A C Freitas; L A Nascimento; N S Melo; E N S Guerra
Journal:  Dentomaxillofac Radiol       Date:  2012-01-12       Impact factor: 2.419

5.  Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.

Authors:  Waseem Jerjes; Tahwinder Upile; Aviva Petrie; Andrew Riskalla; Zaid Hamdoon; Michael Vourvachis; Kostas Karavidas; Amrita Jay; Ann Sandison; Gareth J Thomas; Nicholas Kalavrezos; Colin Hopper
Journal:  Head Neck Oncol       Date:  2010-04-20

6.  Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis.

Authors:  Aditi Bhattacharya; Ritu Roy; Antoine M Snijders; Gregory Hamilton; Jesse Paquette; Taku Tokuyasu; Henrik Bengtsson; Richard C K Jordan; Adam B Olshen; Daniel Pinkel; Brian L Schmidt; Donna G Albertson
Journal:  Clin Cancer Res       Date:  2011-11-08       Impact factor: 12.531

7.  Sentinel lymph node biopsy or elective neck dissection for patients with oral squamous cell carcinoma?

Authors:  Harri Keski-Säntti; Risto Kontio; Jyrki Törnwall; Ilmo Leivo; Sorjo Mätzke; Sinikka Suominen; Esa Leppänen; Timo Atula
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-02       Impact factor: 2.503

8.  Oral hybrid verrucous carcinoma: a clinical study.

Authors:  Sandhya Gokavarapu; L M Chandrasekhara Rao S; Uma Sankar Tantravahi; Sandhya Devi Gundimeda; T Subramaneshwar Rao; Sudha Murthy
Journal:  Indian J Surg Oncol       Date:  2014-08-28

Review 9.  The diagnosis and treatment of oral cavity cancer.

Authors:  Klaus-Dietrich Wolff; Markus Follmann; Alexander Nast
Journal:  Dtsch Arztebl Int       Date:  2012-11-30       Impact factor: 5.594

10.  Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age.

Authors:  Marilena Vered; Dan Dayan; Alex Dobriyan; Ran Yahalom; Bruria Shalmon; Iris Barshack; Lev Bedrin; Yoav P Talmi; Shlomo Taicher
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-07       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.